LGN vs EXPO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
LGN · Legence$32.31 ▼ 7.92%
EXPO · Exponent$89.16 ▲ 0.18%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- LGN -26.2%
- EXPO +28.2%
Head to head
| Metric | LGN | EXPO |
|---|---|---|
| Price | $32.31 | $89.16 |
| Change today | ▼ 7.92% | ▲ 0.18% |
| Market cap | $2.50B | $4.24B |
| Return, 3 months | -42.7% | +26.5% |
| Return, year to date | -24.9% | +30.2% |
| Return, 1 year | -20.8% | +28.5% |
| P/E (TTM) | 55.2 | 38.4 |
| P/B | 3.7 | 13.8 |
| P/E percentile vs own 5y | 100th | 31st |
| Dividend yield | – | 1.38% |
| Revenue growth (YoY, latest qtr) | +85.1% | +18.1% |
| Net profit growth (YoY) | +35,223.7% | +10.3% |
| Gross margin | 19.1% | – |
| Operating margin | 5.6% | 21.3% |
| Net margin | 1.0% | 17.4% |
| Return on equity | 8.4% | 32.3% |
| Analyst target vs. price | +160.7% | +1.7% |
| Analyst buy share | 89% | 75% |
| RSI (14) | 40 | 76 |
| 30-day volatility | 131.8% | 30.1% |
| Max drawdown, 1 year | -75.2% | -32.5% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- EXPO is the largest of the group by market value.
- EXPO has returned the most over the past year.
- EXPO carries the lowest trailing P/E.
- LGN is growing revenue fastest.
- EXPO keeps the most profit per dollar of sales.
- EXPO has been the calmest stock over the last 30 days.